FEDERATED HERMES, INC.

Position in CCCC — C4 Therapeutics, Inc.

CIK 1056288 PITTSBURGH, PA

Position in CCCC

as of Jun 30, 2026 · filed Aug 12, 2026 Compact

Position Value

$8,770

+$3,831 QoQ

Shares Held

1,878

0.0% QoQ

Ownership

0.002%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#137

of 147 holders

Holding Since

Mar 2021

12 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

FEDERATED HERMES, INC. holds $2,455,215,104 across 149 Biotechnology names. CCCC ranks #131 (0.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	ALNY	Alnylam Pharmaceuticals, Inc.	719,905	$216,713,000
2	RYTM	Rhythm Pharmaceuticals, Inc.	1,785,716	$198,268,046
3	REGN	Regeneron Pharmaceuticals, Inc.	256,884	$160,177,448
4	MRNA	Moderna, Inc.	1,794,778	$125,688,301
5	KYMR	Kymera Therapeutics, Inc.	749,398	$85,933,468
6	EYPT	EyePoint, Inc.	5,681,052	$81,239,042
7	ARGX	Argenx SE	87,288	$80,983,187
8	ZBIO	Zenas BioPharma, Inc.	3,116,805	$79,104,510

12 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$8,770	1,878	0.0%	Shares	Defined	2026-08-12
2026-03-31	$4,939	1,878	+75.7%	Shares	Defined	2026-05-11
2025-03-31	$1,710	1,069	+238.3%	Shares	Defined	2025-05-08
2024-06-30	$1,459	316	-89.9%	Shares	Defined	2024-08-08
2023-09-30	$5,842	3,141	+681.3%	Shares	Defined	2023-11-13
2023-06-30	$1,105	402	-88.4%	Shares	Defined	2023-08-14
2023-03-31	$10,854	3,457	-68.8%	Shares	Defined	2023-05-08
2022-12-31	$65,318	11,071	+1012.7%	Shares	Defined	2023-02-13
2022-09-30	$8,726	995	-97.6%	Shares	Defined	2022-11-14
2021-12-31	$1,349,083	41,897	-28.5%	Shares	Defined	2022-02-14
2021-09-30	$2,618,784	58,612	+50.4%	Shares	Defined	2021-11-15
2021-03-31	$1,441,685	38,975	—	Shares	Defined	2021-05-13
No filing history on record for this holder in this stock.